title: New hope or drawbacks: will chronic kidney disease be treatable with small molecules in the near future?
authors.forename: Daniel
authors.initials: D
authors.lastname: Merk
authors.forename: Manfred
authors.initials: M
authors.lastname: Schubert-Zsilavecz
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000276:immunology; D000072019:Kelch-Like ECH-Associated Protein 1; D007668:Kidney / Q000187:drug effects / Q000276:immunology; D051267:NF-E2-Related Factor 2 / Q000276:immunology; D009828:Oleanolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D051436:Renal Insufficiency, Chronic / Q000188:drug therapy* / Q000276:immunology
chemical_list: D000893:Anti-Inflammatory Agents; D047908:Intracellular Signaling Peptides and Proteins; C431364:KEAP1 protein, human; D000072019:Kelch-Like ECH-Associated Protein 1; D051267:NF-E2-Related Factor 2; D009828:Oleanolic Acid; C445068:bardoxolone methyl